Skip to main content
70°
Sunny
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
Classifieds
Place ad
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Cerus Corp
(NQ:
CERS
)
1.820
+0.030 (+1.68%)
Streaming Delayed Price
Updated: 11:16 AM EDT, May 7, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Cerus Corp
< Previous
1
2
3
4
5
Next >
Cerus Corporation Announces Health Canada Approval for INTERCEPT Blood System for Platelets with Seven-Day Storage
November 01, 2022
From
Cerus Corporation
Via
Business Wire
Cerus Corporation to Release Third Quarter 2022 Financial Results on November 3, 2022
October 20, 2022
From
Cerus Corporation
Via
Business Wire
Cerus Corporation Announces Workshop and Abstracts at the 2022 AABB Annual Meeting
September 26, 2022
From
Cerus Corporation
Via
Business Wire
Cerus Corporation Acknowledges Growing Monkeypox Outbreak and Public Health Emergency
August 12, 2022
From
Cerus Corporation
Via
Business Wire
Recap: Cerus Q4 Earnings
February 22, 2022
Cerus (NASDAQ:CERS) reported its Q4 earnings results on Tuesday, February 22, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Cerus beat...
Via
Benzinga
Earnings Scheduled For February 22, 2022
February 22, 2022
Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is projected to report quarterly earnings at $0.13 per share on revenue of $439.63 million. • Sohu...
Via
Benzinga
Cerus Corporation Announces Another Record Quarter and Reiterates Full Year 2022 Product Revenue Guidance Range
August 04, 2022
From
Cerus Corporation
Via
Business Wire
Cerus Corporation to Release Second Quarter 2022 Financial Results on August 4, 2022
July 21, 2022
From
Cerus Corporation
Via
Business Wire
Cerus Corporation Announces Appointment of Hua Shan, MD, PhD to Board of Directors
July 05, 2022
From
Cerus Corporation
Via
Business Wire
Cerus Corporation Celebrates World Blood Donor Day 2022
June 14, 2022
From
Cerus Corporation
Via
Business Wire
Class Of 1997: 25 Years Decades After Their IPOs, Where Are These Companies Now?
May 19, 2022
Delivering on a promise is a tough proposition, and to consistently deliver requires excellence on all fronts.
Via
Benzinga
Cerus Corporation Announces First Quarter 2022 Financial Results and Increases Full Year 2022 Product Revenue Guidance Range
May 05, 2022
From
Cerus Corporation
Via
Business Wire
Cerus Corporation Announces New Manufacturing and Supply Agreement With Fresenius Kabi For INTERCEPT Blood System Sets
May 03, 2022
From
Cerus Corporation
Via
Business Wire
Cerus Corporation Announces Multi-Year Contract for the INTERCEPT Blood System for Platelets with the American Red Cross
April 25, 2022
From
Cerus Corporation
Via
Business Wire
Cerus Corporation to Release First Quarter 2022 Financial Results on May 5, 2022
April 21, 2022
From
Cerus Corporation
Via
Business Wire
Cerus Corporation to Participate at the Cowen 42nd Annual Health Care Conference
February 25, 2022
From
Cerus Corporation
Via
Business Wire
Cerus's Return On Capital Employed Overview
February 23, 2022
According to data from Benzinga Pro, during Q4, Cerus's (NASDAQ:CERS) reported sales totaled $39.87 million. Despite a 26.66% increase in earnings, the company posted a loss of $9...
Via
Benzinga
Cerus Reports Narrower Quarterly Loss As INTERCEPT Platelet Kits Lift Q4 Sales
February 23, 2022
Cerus Corp's (NASDAQ: CERS) Q4 FY21 product revenue was $39.9 million, compared to $28.2 million, driven by increased sales of INTERCEPT platelet kits to blood...
Via
Benzinga
Cerus Corporation Announces Record Fourth Quarter and Full-Year 2021 Financial Results
February 22, 2022
From
Cerus Corporation
Via
Business Wire
Cerus Corporation to Release Fourth Quarter and Full-Year 2021 Financial Results on February 22, 2022
February 08, 2022
From
Cerus Corporation
Via
Business Wire
Cerus Corporation to Participate in Upcoming Virtual Investor Conferences
February 07, 2022
From
Cerus Corporation
Via
Business Wire
12 Health Care Stocks Moving In Thursday's After-Market Session
January 20, 2022
Gainers TCR2 Therapeutics (NASDAQ:TCRR) s...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
January 18, 2022
Gainers DBV Technologies (NASDAQ:DBVT) sh...
Via
Benzinga
Cerus Corporation Announces Record Preliminary Fourth Quarter and Full-Year 2021 Product Revenue and Provides Business Update
January 10, 2022
From
Cerus Corporation
Via
Business Wire
Uncertain Times
December 15, 2021
The UK inflation rate last month was 5.1%, not a good omen.
Via
Talk Markets
Cerus Corporation to Participate in Stephens Annual Investment Conference
November 19, 2021
From
Cerus Corporation
Via
Business Wire
Cerus Corporation to Participate in Stifel 2021 Virtual Healthcare Conference
November 08, 2021
From
Cerus Corporation
Via
Business Wire
86 Biggest Movers From Yesterday
November 04, 2021
Gainers FAT Brands Inc. (NASDAQ: FATBB) shares gained 99.2% to settle at $15.44. FAT Brands recently announced plans to acquire Fazoli’s Restaurant Chain for $130 million....
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
November 03, 2021
Gainers iRhythm Technologies (NASDAQ:IRTC) stock moved upwards by 52.78% to $117.34 during Wednesday's regular session. iRhythm Technologies's stock is trading at...
Via
Benzinga
The Daily Biotech Pulse: Cerus Climbs On Earnings, Horizon CFO To Retire, Teva Prices Upsized Sustainability-Linked Senior Note Offering
November 03, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Horizon Announces Retirement Of CFO, Beat-and-raise Q3 Horizon Therapeutics...
Via
Benzinga
Topics
Retirement
Exposures
Pension
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.